WGBS data from normal hematopoietic cells and AML samples with other mutational profiles were included to define the methylation phenotypes specific to IDH mutations and to determine their relationship to “generic” AML-associated methylation changes. This evidence concerns the gene IDH2 and acute myeloid leukemia.